The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
it's an important number in the sense of if you're a lipoprotein guy trying to figure things out if it's extremely high it increases the risk of pancreatitis but i haven't seen any solid evidence that the triglyceride itself is pro-atherogenic what's atherogenic is the cholesterol inside the vldl particles and it's the number of those particles that get into the wall
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.